Patents by Inventor Thomas Sciascia

Thomas Sciascia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release formulation of nalbuphine
    Patent number: 9351938
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: May 31, 2016
    Assignee: ENDO PHARMACEUTICALS INC
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler, David Verbel, Stanley Au
  • METHODS FOR TREATING PRURITUS
    Publication number: 20150359789
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Application
    Filed: June 12, 2015
    Publication date: December 17, 2015
    Inventor: Thomas SCIASCIA
  • Sustained release formulation of nalbuphine
    Patent number: 9186330
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: November 17, 2015
    Assignee: Endo Pharmaceuticals INC.
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler
  • Methods for treating pruritus
    Patent number: 8987289
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: March 24, 2015
    Assignee: Trevi Therapeutics, Inc.
    Inventor: Thomas Sciascia
  • Methods for treating pruritis
    Patent number: 8940753
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: January 27, 2015
    Assignee: Trevi Therapeutics, Inc.
    Inventor: Thomas Sciascia
  • METHODS FOR TREATING PRURITUS
    Publication number: 20140350042
    Abstract: The present invention relates to methods for treating uremic pruritus with anti-pruritic compositions.
    Type: Application
    Filed: December 23, 2013
    Publication date: November 27, 2014
    Applicant: TREVI THERAPEUTICS, INC.
    Inventor: Thomas SCIASCIA
  • SUSTAINED RELEASE FORMULATION OF NALBUPHINE
    Publication number: 20140315937
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: June 30, 2014
    Publication date: October 23, 2014
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler
  • SUSTAINED RELEASE FORMULATION OF NALBUPHINE
    Publication number: 20140271852
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: May 29, 2014
    Publication date: September 18, 2014
    Applicant: PENWEST PHARMACEUTICALS CO.
    Inventors: Anand R. BAICHWAL, Philip A. GOLIBER, Anthony E. CARPANZANO, Thomas SCIASCIA, Donald DIEHL, II, Brian VOGLER, David VERBEL, Stanley AU
  • Sustained release formulations of nalbuphine
    Patent number: 8771732
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: August 24, 2006
    Date of Patent: July 8, 2014
    Assignee: Endo Pharmaceuticals Inc
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler
  • Sustained release formulation of nalbuphine
    Patent number: 8765175
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: July 1, 2014
    Assignee: Endo Pharmaceuticals Inc
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler, David Verbel, Stanley Au
  • METHODS FOR TREATING PRURITUS
    Publication number: 20140179727
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 26, 2014
    Applicant: TREVI THERAPEUTICS, INC.
    Inventor: Thomas SCIASCIA
  • METHODS FOR TREATING PRURITUS
    Publication number: 20140171459
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 19, 2014
    Applicant: TREVI THERAPEUTICS, INC.
    Inventor: Thomas SCIASCIA
  • Methods for treatment of pruritis
    Patent number: 8637538
    Abstract: The present invention relates to methods for treating uremic pruritus with anti-pruritic compositions.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: January 28, 2014
    Assignee: Trevi Therapeutics, Inc.
    Inventor: Thomas Sciascia
  • Sustained release formulations of nalbuphine
    Patent number: 8394812
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: March 12, 2013
    Assignee: Penwest Pharmaceuticals Co.
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler, David Verbel, Stanley Au
  • Sustained release formulations of nalbuphine
    Publication number: 20090030026
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: May 23, 2008
    Publication date: January 29, 2009
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, II, Brian Vogler, David Verbel, Stanley Au
  • Sustained release torsemide dosage forms
    Publication number: 20070196482
    Abstract: Disclosed in certain embodiments is a sustained release oral dosage form comprising an effective amount of torsemide or a pharmaceutically acceptable salt thereof and a sustained release excipient, wherein the dosage form provides a mean sodium (Na+) excretion and mean sodium (Na+) excretion rate as disclosed herein.
    Type: Application
    Filed: December 15, 2006
    Publication date: August 23, 2007
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Pradeep Sanghvi, Sara Ketsela, Thomas Sciascia, Theodore Jaworski
  • Sustained release formulations of nalbuphine
    Publication number: 20070048376
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 1, 2007
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Anand Baichwal, Philip Goliber, Anthony Carpanzano, Thomas Sciascia, Donald Diehl, Brian Vogler
  • Sustained release torsemide dosage forms
    Publication number: 20050169991
    Abstract: A sustained release pharmaceutical formulation comprising torsemide or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 10, 2004
    Publication date: August 4, 2005
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Pradeep Sanghvi, Sara Ketsela, Thomas Sciascia, Theodore Jaworski